Article

Physiological release of endogenous tau is stimulated by neuronal activity.

Department of Neuroscience (PO37), King's College London, Institute of Psychiatry, London SE5 8AF, UK.
EMBO Reports (Impact Factor: 7.86). 02/2013; DOI: 10.1038/embor.2013.15
Source: PubMed

ABSTRACT Propagation of tau pathology is linked with progressive neurodegeneration, but the mechanism underlying trans-synaptic spread of tau is unknown. We show that stimulation of neuronal activity, or AMPA receptor activation, induces tau release from healthy, mature cortical neurons. Notably, phosphorylation of extracellular tau appears reduced in comparison with intracellular tau. We also find that AMPA-induced release of tau is calcium-dependent. Blocking pre-synaptic vesicle release by tetanus toxin and inhibiting neuronal activity with tetrodotoxin both significantly impair AMPA-mediated tau release. Tau secretion is therefore a regulatable process, dysregulation of which could lead to the spread of tau pathology in disease.

2 Bookmarks
 · 
162 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently a number of aggregation disease polypeptides have been shown to spread from cell to cell thereby displaying prionoid behaviour. Studying aggregate internalisation however is often hampered by the complex kinetics of the aggregation process resulting in the concomitant uptake of aggregates of different sizes by competing mechanisms, which makes it difficult to isolate pathway-specific responses to aggregates. We designed synthetic aggregating peptides bearing different aggregation propensities with the aim of producing modes of uptake that are sufficiently distinct to differentially analyse the cellular response to internalization. We found that small acidic aggregates (≤500 nm diameter) were taken up by non-specific endocytosis as part of the fluid phase and travelled through the endosomal compartment to lysosomes. By contrast, basic bigger aggregates (>1 μm) were taken up through a mechanism dependent of cytoskeletal reorganization and membrane remodelling with the morphological hallmarks of phagocytosis. Importantly, the properties of these aggregates not only determined the mechanism of internalization but also the involvement of the proteostatic machinery (the assembly of interconnected networks that control the biogenesis, folding, trafficking and degradation of proteins) in the process: while the internalization of small acidic aggregates is HSF1 independent, the uptake of larger basic aggregates was HSF1 dependent requiring Hsp70. Our results show that the biophysical properties of aggregates determine both their mechanism of internalisation and proteostatic response. It remains to be seen whether these differences in cellular response contribute to the particular role of specific aggregated proteins in disease.
    Journal of Biological Chemistry 11/2014; · 4.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Filaments made of hyperphosphorylated tau protein are encountered in a number of neurodegenerative diseases referred to as “tauopathies”. In the most prevalent tauopathy, Alzheimer's disease, tau pathology progresses in a stereotypical manner with the first lesions appearing in the locus coeruleus and the entorhinal cortex from where they appear to spread to the hippocampus and neocortex. Propagation of tau pathology is also characteristic of argyrophilic grain disease, where the tau lesions appear to spread throughout distinct regions of the limbic system. These findings strongly implicate neuron-to-neuron propagation of tau aggregates. Isoform composition and morphology of tau filaments can differ between tauopathies suggesting the existence of conformationally diverse tau strains. Altogether, this points to prion-like mechanisms in the pathogenesis of tauopathies.
    Neuropathology and Applied Neurobiology 11/2014; · 4.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A growing body of evidence supports the application of the neurochemical dementia diagnostics (NDD) biomarkers for the diagnosis of dementing conditions. Biomarkers of Alzheimer's disease (AD) were recently classified as these reflecting amyloid β pathology (decreased CSF concentrations of Aβ42 and/or positive Aβ PET scan) and these reflecting neurodegeneration (increased CSF Tau concentrations, decreased uptake of FDG on FDG-PET, and cerebral atrophy on structural MRI). Particularly important seems the role of the biomarkers in the early diagnosis of AD, as the first pathophysiologic events observable in the CSF and amyloid β-PET occur years and perhaps decades before the onset of the earliest clinical symptoms. Therefore, the NDD tools enable the diagnosis of AD already in the early preclinical stage. This review summarizes pathophysiology underlying the CSF biomarkers, following a discussion of their role in the current guidelines for the diagnostic procedures. Copyright © 2014 Medical University of Bialystok. All rights reserved.
    Advances in Medical Sciences 12/2014; 60(1):76-82. · 0.80 Impact Factor

Full-text

Download
134 Downloads
Available from
May 19, 2014